If It’s Okay for Mice, It’s Good Enough for People. Right?

Madhava Setty

The U.S. Food and Drug Administration appears set to circumvent its own regulatory process in order to authorize Pfizer’s new bivalent COVID-19 vaccine that targets the Omicron BA.4 and BA.5 subvariants — without requiring clinical trials on humans.

… Yes, it’s an unprecedented move by the FDA, but Dr. Ofer Levy, professor of pediatrics at Harvard and advisor to the FDA argues that the country has had enough experience with the vaccines at this point to be con dent the shots are safe and that there’s not enough time to wait for data from human studies.

… Can we dispense with the pretense any of this is about health?

… No sane person vaccinates the entire country with an experimental vaccine without trials …

Latest articles

Yuhong Dong In part 1 and part 2 of this series, we...
Yuhong Dong While the underlying mechanisms causing these autoimmune reactions are not...
Yuhong Dong The decline of public trust in COVID-19 vaccines significantly impacts...
Michael Passwater Vitamin D has important influences on many phases in the...
newmedicineonline.com When understanding the construct of an immune system we must begin...
Travis Noakes A major concern is that this agenda lacks earnest discussion...

Thank you!

Thank you for your membership application. As soon as your payment has been received your membership will be activated and you will be informed via email.

Thank you.

Thank you!

The form has been submitted successfully!